e421 Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al
In 2006, the World Health Organization recognized SCD as a global problem with significant economic implications with the incidence expected to rise above 400,000 births per year in 2050 (Piel et al., 2013a
The study was published in the Journal of the American Heart Association
Plevnik Kapun A, Salobir J, Levart A, Tavar Kalcher G, Nemec Svete A, Kotnik T
The Precision Peptide Genetic Test ($99 add-on) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to reveal your genetic predisposition to GLP-1 medication response and metabolic regulation
the Met + Pio group ( n = 75) received metformin plus pioglitazone (500 mg, 15 mg, respectively) and placebo (citric acid plus calcium carbonate), twice daily for 12 weeks